Rodrigo Rocamora

Hospital Del Mar, Pompeu Fabra University

Papers

2

Total Citations

15

H-Index

2

About

Rodrigo Rocamora is a leading figure in epilepsy surgery and neuromodulation, whose work bridges cutting-edge technology and clinical practice to improve outcomes for patients with drug-resistant epilepsy (DRE). His research centers on multimodal surgical planning, minimally invasive interventions, and the refinement of therapeutic protocols. Rocamora spearheaded the development of the SYLVIUS platform, a groundbreaking multidisciplinary tool that integrates neuroimaging, electrophysiology, and surgical data to enhance precision in epilepsy surgery—a contribution that has already garnered significant attention in the field. He has also been at the forefront of advancing MRI-guided laser interstitial thermal therapy (MRIgLITT), demonstrating its efficacy as a less invasive alternative to traditional open surgery. His 2025 study on MRIgLITT outcomes, which analyzes clinical and radiological predictors of success in an adult population, has quickly become a key reference, accumulating 7 citations within its first year. With a career dedicated to translating complex data into actionable surgical strategies, Rocamora’s work directly shapes how clinicians approach refractory epilepsy, offering new hope for seizure control while minimizing patient risk.

Research Focus

Key Achievements

2
H-Index
2
Papers
15
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
SYLVIUS: A multimodal and multidisciplinary platform for epilepsy surgery
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Hospital Del Mar, Pompeu Fabra University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 70 days ago